tiprankstipranks
Trending News
More News >
Option Care Health (OPCH)
NASDAQ:OPCH
US Market
Advertisement

Option Care Health (OPCH) Stock Forecast & Price Target

Compare
472 Followers
See the Price Targets and Ratings of:

OPCH Analyst Ratings

Strong Buy
5Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Option
Care Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

OPCH Stock 12 Month Forecast

Average Price Target

$38.67
▲(35.26% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Option Care Health in the last 3 months. The average price target is $38.67 with a high forecast of $40.00 and a low forecast of $38.00. The average price target represents a 35.26% change from the last price of $28.59.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"22":"$22","41":"$41","26.75":"$26.8","31.5":"$31.5","36.25":"$36.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":40,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$40.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":38.67,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$38.67</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":38,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$38.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[22,26.75,31.5,36.25,41],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28.26,29.163076923076925,30.06615384615385,30.96923076923077,31.872307692307693,32.77538461538462,33.67846153846154,34.581538461538464,35.48461538461539,36.387692307692305,37.29076923076923,38.19384615384615,39.096923076923076,{"y":40,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28.26,29.060769230769232,29.861538461538462,30.662307692307692,31.463076923076926,32.26384615384615,33.06461538461539,33.86538461538461,34.66615384615385,35.46692307692308,36.26769230769231,37.06846153846154,37.86923076923077,{"y":38.67,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28.26,29.009230769230772,29.75846153846154,30.50769230769231,31.25692307692308,32.00615384615385,32.755384615384614,33.504615384615384,34.253846153846155,35.003076923076925,35.752307692307696,36.50153846153846,37.25076923076923,{"y":38,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":30.77,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.02,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.15,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.11,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.12,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.2,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.92,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.5,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.95,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.17,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.86,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.95,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.26,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$40.00Average Price Target$38.67Lowest Price Target$38.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on OPCH
TR | OpenAI - 4o
TR | OpenAI - 4o
$32$30
Hold
4.93%
Upside
Downgraded
08/22/25
AI Generated ArticleAI Generated Article
Truist Financial Analyst forecast on OPCH
Truist Financial
Truist Financial
Buy
Reiterated
08/21/25
Analysts Offer Insights on Healthcare Companies: Option Care Health (NASDAQ: OPCH) and Zoetis (NYSE: ZTS)
William Blair Analyst forecast on OPCH
William Blair
William Blair
Buy
Reiterated
08/20/25
William Blair Sticks to Their Buy Rating for Option Care Health (OPCH)
Barrington Analyst forecast on OPCH
Barrington
Barrington
$38
Buy
32.91%
Upside
Reiterated
07/31/25
Analysts Are Bullish on Top Healthcare Stocks: Neurocrine (NBIX), GE Healthcare Technologies Inc (GEHC)
Citizens JMP
$36$38
Buy
32.91%
Upside
Reiterated
07/31/25
Option Care Health price target raised to $38 from $36 at Citizens JMPOption Care Health price target raised to $38 from $36 at Citizens JMP
UBS
$40
Buy
39.91%
Upside
Reiterated
06/24/25
Option Care Health (OPCH) Gets a Buy from UBS
Bank of America Securities Analyst forecast on OPCH
Bank of America Securities
Bank of America Securities
Buy
Reiterated
05/14/25
Bank of America Securities Remains a Buy on Option Care Health (OPCH)
J.P. Morgan Analyst forecast on OPCH
J.P. Morgan
J.P. Morgan
Buy
Reiterated
04/11/25
Option Care Health: Diversified Revenue Streams Mitigate Impact of Vyvgart Approval, Reinforcing Buy Rating
Jefferies
$40
Buy
39.91%
Upside
Reiterated
04/11/25
Minimal Impact of VYVGART Approval on Option Care Health Justifies Buy Rating
Goldman Sachs Analyst forecast on OPCH
Goldman Sachs
Goldman Sachs
$25$35
Hold
22.42%
Upside
Reiterated
02/28/25
Option Care Health (OPCH) PT Raised to $35 at Goldman SachsGoldman Sachs analyst Jamie Perse raised the price target on Option Care Health (NASDAQ: OPCH) to $35.00 (from $25.00) while maintaining a Neutral rating.
Deutsche Bank  Analyst forecast on OPCH
Deutsche Bank
Deutsche Bank
$36$30
Buy
4.93%
Upside
Reiterated
10/31/24
Option Care Health (OPCH) PT Lowered to $30 at Deutsche BankDeutsche Bank analyst Pito Chickering lowered the price target on Option Care Health (NASDAQ: OPCH) to $30.00 (from $36.00) while maintaining a Buy rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on OPCH
TR | OpenAI - 4o
TR | OpenAI - 4o
$32$30
Hold
4.93%
Upside
Downgraded
08/22/25
AI Generated ArticleAI Generated Article
Truist Financial Analyst forecast on OPCH
Truist Financial
Truist Financial
Buy
Reiterated
08/21/25
Analysts Offer Insights on Healthcare Companies: Option Care Health (NASDAQ: OPCH) and Zoetis (NYSE: ZTS)
William Blair Analyst forecast on OPCH
William Blair
William Blair
Buy
Reiterated
08/20/25
William Blair Sticks to Their Buy Rating for Option Care Health (OPCH)
Barrington Analyst forecast on OPCH
Barrington
Barrington
$38
Buy
32.91%
Upside
Reiterated
07/31/25
Analysts Are Bullish on Top Healthcare Stocks: Neurocrine (NBIX), GE Healthcare Technologies Inc (GEHC)
Citizens JMP
$36$38
Buy
32.91%
Upside
Reiterated
07/31/25
Option Care Health price target raised to $38 from $36 at Citizens JMPOption Care Health price target raised to $38 from $36 at Citizens JMP
UBS
$40
Buy
39.91%
Upside
Reiterated
06/24/25
Option Care Health (OPCH) Gets a Buy from UBS
Bank of America Securities Analyst forecast on OPCH
Bank of America Securities
Bank of America Securities
Buy
Reiterated
05/14/25
Bank of America Securities Remains a Buy on Option Care Health (OPCH)
J.P. Morgan Analyst forecast on OPCH
J.P. Morgan
J.P. Morgan
Buy
Reiterated
04/11/25
Option Care Health: Diversified Revenue Streams Mitigate Impact of Vyvgart Approval, Reinforcing Buy Rating
Jefferies
$40
Buy
39.91%
Upside
Reiterated
04/11/25
Minimal Impact of VYVGART Approval on Option Care Health Justifies Buy Rating
Goldman Sachs Analyst forecast on OPCH
Goldman Sachs
Goldman Sachs
$25$35
Hold
22.42%
Upside
Reiterated
02/28/25
Option Care Health (OPCH) PT Raised to $35 at Goldman SachsGoldman Sachs analyst Jamie Perse raised the price target on Option Care Health (NASDAQ: OPCH) to $35.00 (from $25.00) while maintaining a Neutral rating.
Deutsche Bank  Analyst forecast on OPCH
Deutsche Bank
Deutsche Bank
$36$30
Buy
4.93%
Upside
Reiterated
10/31/24
Option Care Health (OPCH) PT Lowered to $30 at Deutsche BankDeutsche Bank analyst Pito Chickering lowered the price target on Option Care Health (NASDAQ: OPCH) to $30.00 (from $36.00) while maintaining a Buy rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Option Care Health

1 Month
xxx
Success Rate
18/27 ratings generated profit
67%
Average Return
+2.31%
reiterated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +2.31% per trade.
3 Months
xxx
Success Rate
13/27 ratings generated profit
48%
Average Return
+2.64%
reiterated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 48.15% of your transactions generating a profit, with an average return of +2.64% per trade.
1 Year
David S MacdonaldTruist Financial
Success Rate
17/27 ratings generated profit
63%
Average Return
+8.75%
reiterated a buy rating 9 days ago
Copying David S Macdonald's trades and holding each position for 1 Year would result in 62.96% of your transactions generating a profit, with an average return of +8.75% per trade.
2 Years
xxx
Success Rate
20/35 ratings generated profit
57%
Average Return
+22.32%
reiterated a xxx
rating 30 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 57.14% of your transactions generating a profit, with an average return of +22.32% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

OPCH Analyst Recommendation Trends

Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
0
0
0
0
0
Buy
22
24
28
24
19
Hold
1
0
0
0
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
23
24
28
24
20
In the current month, OPCH has received 19 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. OPCH average Analyst price target in the past 3 months is 38.67.
Each month's total comprises the sum of three months' worth of ratings.

OPCH Financial Forecast

OPCH Earnings Forecast

Next quarter’s earnings estimate for OPCH is $0.43 with a range of $0.41 to $0.44. The previous quarter’s EPS was $0.41. OPCH beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.10% of the time in the same period. In the last calendar year OPCH has Outperformed its overall industry.
Next quarter’s earnings estimate for OPCH is $0.43 with a range of $0.41 to $0.44. The previous quarter’s EPS was $0.41. OPCH beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.10% of the time in the same period. In the last calendar year OPCH has Outperformed its overall industry.

OPCH Sales Forecast

Next quarter’s sales forecast for OPCH is $1.41B with a range of $1.37B to $1.44B. The previous quarter’s sales results were $1.42B. OPCH beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 46.91% of the time in the same period. In the last calendar year OPCH has Outperformed its overall industry.
Next quarter’s sales forecast for OPCH is $1.41B with a range of $1.37B to $1.44B. The previous quarter’s sales results were $1.42B. OPCH beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 46.91% of the time in the same period. In the last calendar year OPCH has Outperformed its overall industry.

OPCH Stock Forecast FAQ

What is OPCH’s average 12-month price target, according to analysts?
Based on analyst ratings, Option Care Health’s 12-month average price target is 38.67.
    What is OPCH’s upside potential, based on the analysts’ average price target?
    Option Care Health has 35.26% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is OPCH a Buy, Sell or Hold?
          Option Care Health has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Option Care Health’s price target?
            The average price target for Option Care Health is 38.67. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $40.00 ,the lowest forecast is $38.00. The average price target represents 35.26% Increase from the current price of $28.59.
              What do analysts say about Option Care Health?
              Option Care Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of OPCH?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis